France Gastric Balloons Market Insight
Published: 18 July 2026 | Report Format: Electronic (PDF) | Author: Sanket and Pranali
The France gastric balloons market will grow 11.4% at a steady rate due to rising demand for non-surgical weight-loss solutions, increasing prevalence of clinical obesity, expanding investments in private bariatric and specialized outpatient clinics, and the growing integration of digital tracking technologies with advanced swallowable and endoscopic devices.
France gastric balloons market to 2035 in three short bullet point
- The France gastric balloons market size was estimated at USD 14.5 Million in 2025.
- The market size is expected to grow at a CAGR of around 11.4% from 2025 to 2035.
- The France gastric balloons market size is expected to rise around USD 42.7 Million by 2035.
Notable insights for France gastric balloons market
- Segmentation on the basis of Product Type indicates that Single Gastric Balloon Systems product segment holds the dominant position in the France gastric balloons market in 2025 with a market share of nearly 52% due to its procedural simplicity, cost-effectiveness, and established clinical track record in standard outpatient bariatric care.
- Segmentation on the basis of Administration indicates that Endoscopic Placement segment holds the dominant position in the France gastric balloons market in 2025 with a market share of around 58% due to extensive gastroenterology networks and preference among traditional clinicians, while swallowable systems expand rapidly.
- World-wide projected revenue of Allurion Technologies, Inc. in fiscal year 2025 would be around $65 million, driven by strong international demand for procedureless weight management devices and patient-centric digital monitoring applications.
- It is expected that increasing adoption of combination pathways—pairing transient gastric occupancy with GLP-1 receptor agonists—and patient compliance mobile platforms will fuel sector progression, where gastric balloons offer up to 15% reduction in total body weight and lower immediate procedural recovery periods by 65% over surgical options.
Download the eBook (ToC)
Why Buy This Report
- Gives an in-depth analysis of the impact of trends in non-surgical weight management, modernization in endoscopic instruments, and development in outpatient obesity treatment on the France gastric balloons market growth.
- Provides strategic insights regarding technology innovation such as swallowable capsule technology, real-time wireless wellness applications, adjustable volume balloon configurations, and combination metabolic therapies.
- Assists players to analyze competitive benchmarking, investment in advanced bariatric facilities, specialized healthcare partnerships, and geographic outreach by top device suppliers.
Competitive analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the France gastric balloons market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top companies in France gastric balloons market
- Allurion Technologies, Inc.
- Apollo Endosurgery, Inc. (Boston Scientific)
- Endalis
- Helioscopie
- Spatz FGIA, Inc.
- Medsil (CJSC Medical Silicon Products)
- Districlass Médical SA
- Lexel Medical S.R.L.
- ReShape Lifesciences Inc.
- Obalon Therapeutics, Inc.
Recent developments:
- In March 2026, Allurion Technologies announced the official relaunch and commercial availability of its swallowable gastric balloon system in France following a comprehensive regulatory review and updated safety guidelines.
- In November 2025, Endalis introduced an enhanced version of its long-term fluid-filled intragastric balloon featuring advanced biocompatible silicone material to reduce early removal rates and improve overall patient tolerance.
Market segmentation:
France gastric balloons market, By Product Type
- Single Gastric Balloons
- Dual Gastric Balloons
- Triple Gastric Balloons
- Adjustable Gastric Balloons
- Swallowable/Procedureless Balloons
France gastric balloons market, By Filling Material
- Saline-Filled Gastric Balloons
- Gas-Filled Gastric Balloons
- Dual-Filling Composite Systems
France gastric balloons market, By Administration Type
- Endoscopic Placement
- Swallowable Capsule Administration
- Surgical/Laparoscopic Assisted
France gastric balloons market, By End User
- Hospitals & Public Health Centers
- Specialized Bariatric & Private Clinics
- Ambulatory Surgical Centers (ASCs)
- Medical Aesthetics & Wellness Centers
Expert view :
The market for gastric balloons in France will grow owing to the rise in the demand for minimally invasive and reversible weight-loss alternatives, the growing numbers of overweight and obese patients seeking outpatient procedures, and the expanding private bariatric clinic sector. The integration of digital health tracking platforms, smart scales, and combination regimens combining gastric balloons with anti-obesity medications will enhance patient adherence, minimize adverse side effects, and significantly boost the adoption of intragastric weight-management devices across the French healthcare industry.
Author: Sanket and Pranali By Decisions Advisors and Consulting